cannabidiol oil capsules
/ Tilray
- LARVOL DELTA
Home
Next
Prev
1 to 8
Of
8
Go to page
1
February 14, 2023
Cannabidiol for the Treatment of Anxiety Disorders: An 8-Week Pilot Study
(clinicaltrials.gov)
- P3 | N=50 | Recruiting | Sponsor: McMaster University | Not yet recruiting ➔ Recruiting | Trial completion date: Feb 2023 ➔ Feb 2024 | Trial primary completion date: Jan 2023 ➔ Dec 2023
Enrollment open • Trial completion date • Trial primary completion date • CNS Disorders • General Anxiety Disorder • Mood Disorders • Psychiatry • Social Anxiety Disorder • IL10 • IL2 • IL6
June 08, 2018
Cannabidiol for the Treatment of Anxiety Disorders: An 8-Week Pilot Study
(clinicaltrials.gov)
- P3; N=50; Not yet recruiting; Sponsor: McMaster University
Clinical • New P3 trial • CNS Disorders • General Anxiety Disorder • Mood Disorders • Social Anxiety Disorder • IL10 • IL2 • IL6
September 01, 2020
Cannabidiol for the Treatment of Anxiety Disorders: An 8-Week Pilot Study
(clinicaltrials.gov)
- P3; N=50; Not yet recruiting; Sponsor: McMaster University; Trial completion date: Oct 2020 ➔ Feb 2022; Trial primary completion date: Aug 2020 ➔ Jan 2022
Clinical • Trial completion date • Trial primary completion date • CNS Disorders • General Anxiety Disorder • Mood Disorders • Psychiatry • Social Anxiety Disorder • IL10 • IL2 • IL6
March 23, 2021
Cannabidiol for the Treatment of Anxiety Disorders: An 8-Week Pilot Study
(clinicaltrials.gov)
- P3; N=50; Not yet recruiting; Sponsor: McMaster University; Trial completion date: Feb 2022 ➔ Feb 2023; Trial primary completion date: Jan 2022 ➔ Jan 2023
Clinical • Trial completion date • Trial primary completion date • CNS Disorders • General Anxiety Disorder • Mood Disorders • Psychiatry • Social Anxiety Disorder • IL10 • IL2 • IL6
December 21, 2020
Trial of Cannabis for Essential Tremor
(clinicaltrials.gov)
- P1/2; N=7; Completed; Sponsor: University of California, San Diego; Recruiting ➔ Completed; N=16 ➔ 7
Clinical • Enrollment change • Trial completion • Essential Tremor • Movement Disorders
September 25, 2020
Cannabinoid Therapy for Pediatric Epilepsy
(clinicaltrials.gov)
- P1; N=20; Active, not recruiting; Sponsor: The Hospital for Sick Children; Trial completion date: Dec 2020 ➔ Jun 2021
Clinical • Trial completion date • CNS Disorders • Epilepsy • Pediatrics
May 29, 2020
Trial of Cannabis for Essential Tremor
(clinicaltrials.gov)
- P1/2; N=16; Recruiting; Sponsor: University of California, San Diego; Trial completion date: Dec 2019 ➔ Dec 2020; Trial primary completion date: Aug 2019 ➔ Sep 2020
Clinical • Trial completion date • Trial primary completion date • Essential Tremor • Movement Disorders • Solid Tumor
April 15, 2020
Cannabinoid Therapy for Pediatric Epilepsy
(clinicaltrials.gov)
- P1; N=20; Active, not recruiting; Sponsor: The Hospital for Sick Children; Trial completion date: Jun 2020 ➔ Dec 2020
Clinical • Trial completion date • CNS Disorders • Epilepsy • Pediatrics
1 to 8
Of
8
Go to page
1